David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.33% |
| 2 | Technology | 14.87% |
| 3 | Consumer Discretionary | 9.92% |
| 4 | Healthcare | 7.34% |
| 5 | Financials | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Dillards
DDS
$9.87B
| $3.86M | ﹤0.01% |
22,349
-12,459
| -36% | -$2.37M |
|
|
LFLY
2227
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
| $3.86M | ﹤0.01% |
19,300
+6,457
| +50% | +$1.29M |
|
|
HMCO
2228
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
| $3.86M | ﹤0.01% |
389,840
+98,152
| +34% | +$956K |
|
2229
V2X
VVX
$2.47B
| $3.85M | ﹤0.01% |
76,561
-6,449
| -8% | -$305K |
|
2230
Ormat Technologies
ORA
$6.48B
| $3.84M | ﹤0.01% |
57,622
-63,407
| -52% | -$4.38M |
|
|
ONIT
2231
Onity Group
ONIT
$288M
| $3.84M | ﹤0.01% |
136,455
-14,906
| -10% | -$412K |
|
2232
CALL
Goodyear
GT
$1.78B
| $3.84M | ﹤0.01% |
216,800
-40,000
| -16% | -$649K |
|
2233
PUT
ZTO Express
ZTO
$16.1B
| $3.83M | ﹤0.01% |
125,000
+20,000
| +19% | +$574K |
|
|
PPGH
2234
DELISTED
Poema Global Holdings Corp. Class A Ordinary Share
PPGH
| $3.81M | ﹤0.01% |
+386,293
| New | +$3.76M |
|
|
OCDX
2235
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $3.81M | ﹤0.01% |
205,905
+188,755
| +1,101% | +$3.8M |
|
2236
CALL
SL Green Realty
SLG
$4.11B
| $3.8M | ﹤0.01% |
53,700
+40,000
| +292% | +$2.92M |
|
|
MRO
2237
PUT
DELISTED
Marathon Oil Corporation
MRO
| $3.79M | ﹤0.01% |
277,600
-142,200
| -34% | -$1.71M |
|
|
VPCB
2238
DELISTED
VPC Impact Acquisition Holdings II Class A ordinary shre
VPCB
| $3.79M | ﹤0.01% |
384,755
+318,089
| +477% | +$3.13M |
|
2239
MidCap Financial Investment
MFIC
$797M
| $3.79M | ﹤0.01% |
292,158
-17,688
| -6% | -$241K |
|
2240
CALL
Repligen
RGEN
$10.3B
| $3.79M | ﹤0.01% |
+13,100
| New | +$3.36M |
|
2241
PUT
Intuit
INTU
$95.2B
| $3.78M | ﹤0.01% |
+7,000
| New | +$3.77M |
|
|
THR
2242
DELISTED
Thermon Group Holdings
THR
| $3.77M | ﹤0.01% |
218,084
-6,280
| -3% | -$104K |
|
2243
PUT
Cameco
CCJ
$46.4B
| $3.77M | ﹤0.01% |
173,500
+89,900
| +108% | +$1.7M |
|
|
TARO
2244
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $3.77M | ﹤0.01% |
59,196
-3,148
| -5% | -$218K |
|
2245
SkinHealth Systems
SKIN
$91.8M
| $3.76M | ﹤0.01% |
+144,859
| New | +$3.19M |
|
|
EPWR
2246
DELISTED
Empowerment & Inclusion Capital I Corp.
EPWR
| $3.76M | ﹤0.01% |
384,209
+102,119
| +36% | +$1M |
|
|
PNTM
2247
DELISTED
Pontem Corporation
PNTM
| $3.76M | ﹤0.01% |
386,830
+60,946
| +19% | +$591K |
|
2248
Dragonfly Energy
DFLI
$17.7M
| $3.75M | ﹤0.01% |
+4,193
| New | +$3.73M |
|
2249
Comscore
SCOR
$80.2M
| $3.75M | ﹤0.01% |
48,023
-15,618
| -25% | -$1.24M |
|
|
GETR
2250
DELISTED
Getaround, Inc.
GETR
| $3.74M | ﹤0.01% |
382,598
+282,598
| +283% | +$2.75M |
|
Similar funds
David Shaw's Q3 2021 Portfolio in Review
As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $13.7B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Sea Limited worth $206M.
- David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- David Shaw opened 915 new positions and closed 695 in Q3 2021.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.